Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000197580 | SCV000249894 | pathogenic | not provided | 2014-03-15 | criteria provided, single submitter | clinical testing | Although the c.5357dupT variant in the COL5A1 gene has not been reported to our knowledge, this variant causes a shift in reading frame starting at codon Aspartic acid 1787, changing it to a Glycine, and creating a premature stop codon at position 33 of the new reading frame, denoted p.Asp1787GlyfsX33. This variant is expected to result in an abnormal, truncated protein product. Numerous other frameshift mutations in the COL5A1 gene have been reported in association with classic-type EDS (Malfait F et al., 2011).In summary, c.5357dupT in the COL5A1 gene is interpreted as a pathogenic variant. |
Fulgent Genetics, |
RCV002492887 | SCV002778796 | pathogenic | Ehlers-Danlos syndrome, classic type, 1; Fibromuscular dysplasia, multifocal | 2021-12-16 | criteria provided, single submitter | clinical testing |